Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -79.29%. However, over the last six months, the performance has been stronger by -16.77%. The price of ESPR decreased -10.42% over the last 30 days. And in the last five days, it has fallen by -3.01%.
Esperion Therapeutics Inc. (ESPR) stock is currently valued at $1.29. During the last session, the stock experienced a remarkable rise, reaching $1.4499 after opening at $1.42. The stock briefly dropped to $1.29 before ultimately closing at $1.42.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
The market performance of Esperion Therapeutics Inc.’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $8.87 on 12/07/22, while the lowest value for the same duration was $1.12 on 04/26/23.
52-week price history of ESPR Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Esperion Therapeutics Inc.’s current trading price is -85.46% away from its 52-week high, while its distance from the 52-week low is 15.18%. The stock’s price range during this time has been between $1.12 and $8.87. The trading volume for the Healthcare sector company’s shares reached about 4.62 million for the day, which was higher than the average daily volume of 3.14 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Esperion Therapeutics Inc. (ESPR) has experienced a quarterly decline of -9.15% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 134.17M and boasts a workforce of 199 employees.
Esperion Therapeutics Inc.: Analysts’ Ratings Unveiled
As of right now, 7 analysts are rating Esperion Therapeutics Inc. as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4726, with a change in price of +0.0900. Similarly, Esperion Therapeutics Inc. recorded 2,848,795 in trading volume during the last 100 days, posting a change of +7.50%.
ESPR Stock Stochastic Average
Today, Esperion Therapeutics Inc.’s raw stochastic average for the past 50 days stands at 1.41%, indicating a decline from the raw stochastic average of the last 20 days, which was 1.85%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 15.43% and 13.50% respectively.
